$0.92
11.75% yesterday
Nasdaq, Jun 27, 10:00 pm CET
ISIN
US44984F3029
Symbol
IVF

INVO Fertility Stock price

$0.92
-0.73 44.38% 1M
-9.01 90.76% 6M
-8.80 90.56% YTD
-9.51 91.20% 1Y
-179.08 99.49% 3Y
-1,439.08 99.94% 5Y
-3,378.28 99.97% 10Y
-3,071.08 99.97% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
-0.12 11.75%
ISIN
US44984F3029
Symbol
IVF

Key metrics

Basic
Market capitalization
$2.0m
Enterprise Value
$7.6m
Net debt
$5.6m
Cash
$840.0k
Shares outstanding
750.0k
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.30 | 0.28
EV/Sales
1.15 | 1.08
EV/FCF
negative
P/B
0.09
Financial Health
Equity Ratio
43.50%
Return on Equity
-46.26%
ROCE
-70.12%
ROIC
-46.35%
Debt/Equity
0.89
Financials (TTM | estimate)
Revenue
$6.6m | $7.1m
EBITDA
$-8.2m | -
EBIT
$-9.1m
Net Income
$-25.2m | $-840.0k
Free Cash Flow
$-6.4m
Growth (TTM | estimate)
Revenue
55.06% | 7.98%
EBITDA
-63.67% | -
EBIT
-68.61%
Net Income
-255.23% | 91.02%
Free Cash Flow
-47.02%
Margin (TTM | estimate)
Gross
41.57%
EBITDA
-124.42% | -
EBIT
-138.48%
Net
-381.53% | -11.92%
Free Cash Flow
-97.20%
More
EPS
$-18.10
FCF per Share
$-8.54
Short interest
0.05%
Employees
-
Rev per Employee
-
Show more

Is INVO Fertility a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

INVO Fertility Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a INVO Fertility forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a INVO Fertility forecast:

Buy
80%
Hold
20%

Financial data from INVO Fertility

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
6.59 6.59
55% 55%
100%
- Direct Costs 3.85 3.85
50% 50%
58%
2.74 2.74
62% 62%
42%
- Selling and Administrative Expenses 10 10
54% 54%
155%
- Research and Development Expense 0.75 0.75
733% 733%
11%
-8.20 -8.20
64% 64%
-124%
- Depreciation and Amortization 0.93 0.93
127% 127%
14%
EBIT (Operating Income) EBIT -9.13 -9.13
69% 69%
-139%
Net Profit -25 -25
255% 255%
-382%

In millions USD.

Don't miss a Thing! We will send you all news about INVO Fertility directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

INVO Fertility Stock News

Neutral
GlobeNewsWire
3 days ago
SARASOTA, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility sector, today announced it has received a notice of allowance on a new patent for a modified version of the Company's proprietary INVOcell device.
Neutral
GlobeNewsWire
8 days ago
SARASOTA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility focused company, reminds shareholders to vote their shares online ahead of the upcoming annual meeting of shareholders (the "Annual Meeting") to be held on June 25, 2025 at 12:00 p.m.
Neutral
GlobeNewsWire
10 days ago
MIDDLETON, Wis. and SARASOTA, Fla.
More INVO Fertility News

Company Profile

INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.

Head office United States
CEO Steven Shum
Founded 2007
Website www.invobioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today